{"pmid":32346094,"pmcid":"PMC7187801","title":"COVID-19 vaccine design: the Janus face of immune enhancement.","text":["COVID-19 vaccine design: the Janus face of immune enhancement.","Nat Rev Immunol","Hotez, Peter J","Corry, David B","Bottazzi, Maria Elena","32346094"],"journal":"Nat Rev Immunol","authors":["Hotez, Peter J","Corry, David B","Bottazzi, Maria Elena"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32346094","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1038/s41577-020-0323-4","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138495374065667,"score":9.490897,"similar":[{"pmid":32305501,"pmcid":"PMC7162764","title":"The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement.","text":["The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement.","Increasing evidence points to host Th17 inflammatory responses as contributing to the severe lung pathology and mortality of lower respiratory tract infections from coronaviruses. This includes host inflammatory and cytokine responses to COVID-19 caused by the SARS-2 coronavirus (SARS CoV2). From studies conducted in laboratory animals, there are additional concerns about immune enhancement and the role of potential host immunopathology resulting from experimental human COVID-19 vaccines. Here we summarize evidence suggesting there may be partial overlap between the underlying immunopathologic processes linked to both coronavirus infection and vaccination, and a role for Th17 in immune enhancement and eosinophilic pulmonary immunopathology. Such findings help explain the link between viral-vectored coronavirus vaccines and immune enhancement and its reduction through alum adjuvants. Additional research may also clarify links between COVID-19 pulmonary immunopathology and heart disease.","Microbes Infect","Hotez, Peter J","Bottazzi, Maria Elena","Corry, David B","32305501"],"abstract":["Increasing evidence points to host Th17 inflammatory responses as contributing to the severe lung pathology and mortality of lower respiratory tract infections from coronaviruses. This includes host inflammatory and cytokine responses to COVID-19 caused by the SARS-2 coronavirus (SARS CoV2). From studies conducted in laboratory animals, there are additional concerns about immune enhancement and the role of potential host immunopathology resulting from experimental human COVID-19 vaccines. Here we summarize evidence suggesting there may be partial overlap between the underlying immunopathologic processes linked to both coronavirus infection and vaccination, and a role for Th17 in immune enhancement and eosinophilic pulmonary immunopathology. Such findings help explain the link between viral-vectored coronavirus vaccines and immune enhancement and its reduction through alum adjuvants. Additional research may also clarify links between COVID-19 pulmonary immunopathology and heart disease."],"journal":"Microbes Infect","authors":["Hotez, Peter J","Bottazzi, Maria Elena","Corry, David B"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305501","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.micinf.2020.04.005","topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138493363945474,"score":52.997395},{"pmid":32255491,"title":"ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19.","text":["ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19.","Angiotensin converting enzyme 2 (ACE2) is the major enzyme responsible for conversion of Ang II into Ang-(1-7). It also acts as the receptor for severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2, which causes Coronavirus Disease (COVID)-19. In recognition of the importance of ACE2 and to celebrate 20 years since its discovery, the journal will publish a focused issue on the basic science and (patho)physiological role of this multifunctional protein.","Clin Sci (Lond)","Touyz, Rhian M","Li, Hongliang","Delles, Christian","32255491"],"abstract":["Angiotensin converting enzyme 2 (ACE2) is the major enzyme responsible for conversion of Ang II into Ang-(1-7). It also acts as the receptor for severe acute respiratory syndrome (SARS)-coronavirus (CoV)-2, which causes Coronavirus Disease (COVID)-19. In recognition of the importance of ACE2 and to celebrate 20 years since its discovery, the journal will publish a focused issue on the basic science and (patho)physiological role of this multifunctional protein."],"journal":"Clin Sci (Lond)","authors":["Touyz, Rhian M","Li, Hongliang","Delles, Christian"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32255491","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1042/CS20200363","keywords":["ace2 receptor","angiotensin","covid-19","cardiovascular","coronavirus","hypertension"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138493089218561,"score":48.498398},{"pmid":32339701,"pmcid":"PMC7195037","title":"Potential role of Janus kinase inhibitors in COVID-19.","text":["Potential role of Janus kinase inhibitors in COVID-19.","J Am Acad Dermatol","Napolitano, Maddalena","Fabbrocini, Gabriella","Patruno, Cataldo","32339701"],"journal":"J Am Acad Dermatol","authors":["Napolitano, Maddalena","Fabbrocini, Gabriella","Patruno, Cataldo"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32339701","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jaad.2020.04.098","keywords":["covid-19","jak inhibitors","atopic dermatitis","baricitinib","infection","upadacitinib"],"locations":["Janus"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138494227972098,"score":47.984478},{"pmid":32259575,"pmcid":"PMC7128600","title":"Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19.","text":["Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19.","The Wuhan outbreak of novel Corona virus infection has been the global focus since December 2019. This infection has become a global pandemic. It is highly important to understand the virology of the pathogen and to explore the therapeutic options for management of this pandemic. Drug repurposing strategies are being considered for management of COVID 19. Among the identified drugs, Baricitinib has become a keen interest for researchers because of its ability to inhibit the viral assembly by the prevention of Clarithrin associated endocytosis. We tried to explore the reasons on why Baricitinib is not an ideal option for COVID 19.","Int J Antimicrob Agents","Praveen, D","Puvvada, Ranadheer Chowdary","M, Vijey Aanandhi","32259575"],"abstract":["The Wuhan outbreak of novel Corona virus infection has been the global focus since December 2019. This infection has become a global pandemic. It is highly important to understand the virology of the pathogen and to explore the therapeutic options for management of this pandemic. Drug repurposing strategies are being considered for management of COVID 19. Among the identified drugs, Baricitinib has become a keen interest for researchers because of its ability to inhibit the viral assembly by the prevention of Clarithrin associated endocytosis. We tried to explore the reasons on why Baricitinib is not an ideal option for COVID 19."],"journal":"Int J Antimicrob Agents","authors":["Praveen, D","Puvvada, Ranadheer Chowdary","M, Vijey Aanandhi"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259575","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ijantimicag.2020.105967","keywords":["baricitinib","covid 19","novel corona virus","sars-cov-2"],"locations":["Wuhan","Clarithrin","Janus"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["baricitinib"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1666138493153181697,"score":44.84391},{"pmid":32335097,"pmcid":"PMC7179491","title":"SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?","text":["SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?","Diabetes could be a risk factor for severity and mortality in patients with coronavirus disease 2019 COVID-19. It has been hypothesized that DPP4 inhibition, a therapy currently available for type 2 diabetes, might represent a target for decreasing the risk of the acute respiratory complications of the COVID-19 infection but (1) lack of demonstration of SARS-CoV2 binding to DPP4 (2) possible protective role of sDPP4 in Middle East respiratory Syndrome (MERS-CoV) (3) demonstrated inhibition and downregulation of DPP4 by HIV1 and MERS-CoV and (4) not exclusive role of the receptor binding in tropism of the Coronavirus family, support that DPP4 inhibition at present doesn't represent a plausible approach to mitigate COVID-19.","Diabetes Res Clin Pract","Pitocco, Dario","Tartaglione, Linda","Viti, Luca","Di Leo, Mauro","Pontecorvi, Alfredo","Caputo, Salvatore","32335097"],"abstract":["Diabetes could be a risk factor for severity and mortality in patients with coronavirus disease 2019 COVID-19. It has been hypothesized that DPP4 inhibition, a therapy currently available for type 2 diabetes, might represent a target for decreasing the risk of the acute respiratory complications of the COVID-19 infection but (1) lack of demonstration of SARS-CoV2 binding to DPP4 (2) possible protective role of sDPP4 in Middle East respiratory Syndrome (MERS-CoV) (3) demonstrated inhibition and downregulation of DPP4 by HIV1 and MERS-CoV and (4) not exclusive role of the receptor binding in tropism of the Coronavirus family, support that DPP4 inhibition at present doesn't represent a plausible approach to mitigate COVID-19."],"journal":"Diabetes Res Clin Pract","authors":["Pitocco, Dario","Tartaglione, Linda","Viti, Luca","Di Leo, Mauro","Pontecorvi, Alfredo","Caputo, Salvatore"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335097","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.diabres.2020.108162","keywords":["ace 2","covid 19","dpp4","diabetes"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666138494076977152,"score":44.84391}]}